Collegium's Revenue Outlook And CNS Expansion Signal Undervalued Opportunity, Says Needham

Benzinga01:38

Needham Upgrades Collegium Pharmaceutical(COLL.US) to Buy Rating, Announces Target Price $46

Futu NewsJan 10 20:34 · Ratings

Collegium Pharmaceutical Price Target Announced at $46.00/Share by Needham

Dow JonesJan 10 20:00 · Ratings

HC Wainwright & Co. Reiterates Buy on Collegium Pharmaceutical, Maintains $50 Price Target

BenzingaJan 10 19:17 · Ratings

Collegium Pharmaceutical Analyst Ratings

BenzingaJan 10 19:11 · Ratings

Pharma Companies Welcome New Year With 583 Drug Price Hikes so Far

Seeking AlphaJan 10 04:36